Advances in
eISSN: 2572-8490
Submit manuscript...
Mini Review Volume 5 Issue 1
Global adaptation of engineered tissue technology; current status and future prospects
Amar Kalsoom
Department of Microbiology, University of Swabi Khyber Pakhtunkhwa, Pakistan
Received: December 23, 2017 | Published: March 26, 2019
Citation: Kalsoom A. Global adaptation of engineered tissue technology; current status and future prospects. Adv Tissue Eng Regen Med Open Access. 2019;5(1):47-51. DOI: 10.15406/atroa.2019.05.00098
Abstract
The tissue engineering technology/engineered tissue technology has met remarkable success in the recently concluding decade and is replacing the standard, common place medical therapies as they are rendered ineffective and less preferable because of the extraordinary advances achieved in the field of tissue regeneration owing to the global adaptation of tissue engineering technology as a regular and effective mean of therapeutic intervention against various medical conditions. The increasing trend is particularly prompted by the global regulatory framework, setup and effectively implemented by the governments and health care organizations across the globe which has allowed the consistent development of advance technologies and an exponential increase in the research funding for alternative regenerative medicine therapies. These efforts has allowed the development of tissue engineering technology /engineered tissue technology into a global market of valuable interest not only in terms of financial turnaround but also as an intellectual paradigm for other sciences and research areas. It is roughly estimated that the global tissue engineering technology is expected to reach 11.53 billion by 2022 according to a new report by Grand view research, Inc. 2016.The use of stem cells co-culturing provides more resolute approach towards the development and growth of tissue engineering technology into a more convenient and effective therapeutic tools against variety of complications including those inherited by birth.
Keywords: tissue engineering technology, regenerative medicine/therapy, stem cells, co-culture, scaffold, signaling molecules/growth factors, extra cellular matrix
©2019 Kalsoom. This is an open access article distributed under the terms of the, which permits unrestricted use, distribution, and build upon your work non-commercially.